Top Section/Ad
Top Section/Ad
Most recent
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
Eight banks provided loan facility to company
More articles/Ad
More articles/Ad
More articles
-
Novo Nordisk bought £50m of the deal leaving £30m for the market -
Flurry of deals in euros with more to come as Monday supply already beats last week’s total volume
-
Third step of Clariane's four-legged debt restructuring plan was 1.67 times oversubscribed
-
Evidence grows that companies can sell bonds successfully any day of the week
-
Valuation mismatch between issuer and investors prompted the decision to cancel the IPO
-
Online pharmacy concludes the issue of convertible bonds, a delta placement and a tender offer
